Neuronetics, inc. (STIM)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18
Cash Flows from Operating Activities:
Net loss

-12,613

-7,554

-6,867

-7,094

-7,529

-6,143

-4,961

-7,496

-5,497

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization

301

300

308

253

204

211

208

324

139

Share-based compensation

1,196

976

935

1,022

501

379

1,028

192

144

Non-cash interest expense

782

198

193

185

177

197

201

194

247

Change in fair value of convertible preferred stock warrant liability

-

-

-

-

-

0

-19

1,408

7

Cost of rental units purchased by customers

70

79

67

50

27

81

69

13

66

Loss on extinguishment of debt

-622

-

-

-

-

-

-

-

-

Changes in certain assets and liabilities:
Accounts receivable, net

-383

-983

717

1,169

47

337

559

442

15

Inventory

104

-149

373

141

-59

-332

389

80

298

Net investments in sales-type leases

368

836

1,134

280

360

-

-

-

-

Leasehold reimbursement

-836

-

-

-

-

-

-

-

-

Prepaid commission expense

419

-

-

-

515

-

-

-

-

Prepaid expenses and other assets

-285

748

758

-437

-504

-61

678

-161

-219

Accounts payable

-1,299

289

238

1,247

-1,475

1,200

-505

-352

263

Accrued expenses

-3,227

1,469

1,124

192

-1,236

1,409

669

976

-3,106

Deferred revenue

-95

-147

651

-486

120

351

35

18

-453

Deferred rent

-

-

-

-

-

17

17

16

13

Net Cash Used in Operating Activities

-13,650

-6,403

-7,661

-6,848

-9,570

-2,276

-4,918

-5,100

-8,297

Cash Flows from Investing Activities:
Purchases of property and equipment and capitalized software

266

359

56

124

274

361

137

216

297

Net Cash Used in Investing Activities

-266

-359

-56

-124

-274

-361

-137

-216

-297

Cash Flows from Financing Activities:
Proceeds from issuance of long-term debt

35,000

-

-

-

-

-

-

-

-

Repayment of long-term debt

32,500

-

-

-

-

-

-

-

-

Payments of debt issuance costs

721

-

-

-

-

-

-

-

-

Payments of public offering costs

-

-

-

-

-

-2

2,734

501

230

Proceeds from exercises of stock options

76

100

443

470

1,407

458

7

7

31

Net Cash Provided by Financing Activities

1,855

100

443

470

1,407

460

97,271

-494

-199

Net Decrease in Cash and Cash Equivalents

-12,061

-6,662

-7,274

-6,502

-8,437

-2,177

92,216

-5,810

-8,793

Supplemental disclosure of cash flow information:
Cash paid for interest

1,403

709

746

757

737

729

723

706

628

Transfer of inventory to property and equipment

-

0

0

0

37

130

-26

92

169

Supplemental disclosure of non-cash investing and financing activities:
Purchases of property and equipment and capitalized software in accounts payable and accrued expenses

94

346

18

-31

44

-

-

-

-

Deferred initial public offering costs included in accounts payable and accrued expenses

-

-

-

-

-

-

-

1,203

1,339